Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Intellia Therapeutics, Inc.

NASDAQ: NTLA · Life Sciences · 6 alerts · CIK 1652130

Share price
$9.86Close, Nov 16
Market cap
$1.38B
Shares outstanding
140.36MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Intellia Therapeutics, Inc. filings on SEC EDGAR ↗

4:21 PM ET Form 4
Insider Selling

Intellia Therapeutics President and CEO John M. Leonard Sells $108K of Stock

John M. Leonard, President and CEO, sold 9,000 shares of Intellia Therapeutics, Inc. at $11.99 a share, worth $108K in total on Nov 2, 2026. Shares held after the trade: 1,138,064 (-0.8%).

Value
$108K
Shares
9,000
Price
$11.99
Role
President and CEO
Holding change
-0.8%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.